Webinar via Microsoft Teams Live Event
Please click on this link just before the start of the webinar
Kirby Institute Seminar Series presents
Professor John Kaldor
John Kaldor is a NHMRC Senior Principal Research Fellow and UNSW Scientia Professor. He holds a doctorate in Biostatistics from the University of California. Berkeley, and began his research career at the International Agency for Research on Cancer in Lyon, France. For over 30 years he has built and led internationally recognised research programs at UNSW on the epidemiology and prevention of infectious diseases.
His research has covered a wide range of projects, including the development and implementation of public health surveillance systems, investigations of infection-related cancer, cohort and cross-sectional investigations of risk factors for infectious disease transmission, and interventional trials of disease prevention strategies.
With over 750 peer reviewed scientific publications that have been cited collectively over 30,000 times, Professor Kaldor has been a highly influential contributor to public health knowledge. His work has guided policy in disease control, particularly in relation to the prevention of HIV infection and other sexually transmitted infections, viral hepatitis and neglected tropical diseases. Professor Kaldor has also served on numerous policy and advisory committees in Australia and Internationally. He has had close working relationships with public health programs in a number of countries of the Asia-Pacific region, particularly Cambodia, Indonesia, Papua New Guinea, Fiji and Solomon Islands.
The Australian Government has published a surveillance plan to guide our response to the COVID-19 pandemic. The plan is intended to support government decision making, and contains multiple elements that are at various stages of implementation and dissemination. At the same time the plan needs to take account of the continuing torrent of information on various aspects of COVID-19 in Australia. Development and implementation of the plan has had to overcome a range of methodological and administrative hurdles, due to both issues that are longstanding in Australia’s national public health architecture, as well as those that are related to the novel features of COVID-19.